Combining in vivo models with Evotec’s state-of-the-art high content histology and imaging platform will accelerate your drug target discovery program and will allow you to monitor disease relevant biomarkers at the site where the biology happens and to get deeper insights into targeted cellular effects within their native environment.
By turning complex cellular events, observed in tissue, into statistically and pharmacologically relevant information, Evotec’s state-of-the-art high content imaging platform will add significant value to your drug target validation, drug efficacy study and biomarker analysis.
Based on the world class Opera™ platform, pathway and phenotypic readouts become possible in tissue slices and thus enable a powerful new approach to target validation and phenotypic analysis of animal models on a cellular basis.
Automated multicolour, multi-parameter fluorescence imaging combined with a powerful toolbox of image analysis algorithms will allow to capture the information on multiple targets and cellular events for a large number of tissue slices and animals. Consequently, this allows analyzing in vivo studies or animals with different genotypes on a cellular level within the tissue of relevance for your drug discovery effort.